Globus Medical Inc (GMED) stock
GMEDNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 22/3044% below fair value
$69.99−0.51 (-0.72%)
Close on Nov 17, 2026Market cap $9.40BP/E 17.9Yield –
Globus Medical r&d expenses
Research and development expenses are spending on new products and technology.
Globus Medical's R&D Expenses for the twelve months ending Jun 30, 2026 was $147.06M, up 3.7% year over year. For fiscal 2025 it was $147.25M, down 10.1% from the year before. Over ten years it grew 15.0% a year on average. The highest annual figure on record is $163.75M in fiscal 2024.
Annual r&d expenses
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $147.25M | -10.1% |
| FY2024 | Dec 31, 2024 | $163.75M | +32.0% |
| FY2023 | Dec 31, 2023 | $124.01M | +69.8% |
| FY2022 | Dec 31, 2022 | $73.02M | -25.0% |
| FY2021 | Dec 31, 2021 | $97.35M | +15.2% |
| FY2020 | Dec 31, 2020 | $84.52M | +40.7% |
| FY2019 | Dec 31, 2019 | $60.07M | +8.2% |
| FY2018 | Dec 31, 2018 | $55.50M | +27.1% |
| FY2017 | Dec 31, 2017 | $43.68M | -1.9% |
| FY2016 | Dec 31, 2016 | $44.53M | +22.6% |
| FY2015 | Dec 31, 2015 | $36.31M | +16.5% |
| FY2014 | Dec 31, 2014 | $31.17M | +16.0% |
| FY2013 | Dec 31, 2013 | $26.87M | -3.8% |
| FY2012 | Dec 31, 2012 | $27.93M | +19.0% |
| FY2011 | Dec 31, 2011 | $23.46M | +10.1% |
| FY2010 | Dec 31, 2010 | $21.31M | – |
Quarterly r&d expenses
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $36.32M | -9.1% |
| Q1 FY2026 | Mar 31, 2026 | $36.51M | +10.4% |
| Q4 FY2025 | Dec 31, 2025 | $36.16M | +8.2% |
| Q3 FY2025 | Sep 30, 2025 | $38.07M | +7.6% |
| Q2 FY2025 | Jun 30, 2025 | $39.95M | +6.0% |
| Q1 FY2025 | Mar 31, 2025 | $33.06M | -42.3% |
| Q4 FY2024 | Dec 31, 2024 | $33.41M | -36.1% |
| Q3 FY2024 | Sep 30, 2024 | $35.38M | +20.6% |
| Q2 FY2024 | Jun 30, 2024 | $37.70M | +76.6% |
| Q1 FY2024 | Mar 31, 2024 | $57.27M | +171.6% |
| Q4 FY2023 | Dec 31, 2023 | $52.25M | +167.9% |
| Q3 FY2023 | Sep 30, 2023 | $29.33M | +56.8% |
| Q2 FY2023 | Jun 30, 2023 | $21.35M | +22.7% |
| Q1 FY2023 | Mar 31, 2023 | $21.08M | +21.1% |
| Q4 FY2022 | Dec 31, 2022 | $19.51M | -61.8% |
| Q3 FY2022 | Sep 30, 2022 | $18.70M | +18.0% |
| Q2 FY2022 | Jun 30, 2022 | $17.40M | +11.9% |
| Q1 FY2022 | Mar 31, 2022 | $17.41M | +16.7% |
| Q4 FY2021 | Dec 31, 2021 | $51.02M | +234.8% |
| Q3 FY2021 | Sep 30, 2021 | $15.85M | +9.9% |
| Q2 FY2021 | Jun 30, 2021 | $15.55M | -60.6% |
| Q1 FY2021 | Mar 31, 2021 | $14.92M | -3.1% |
| Q4 FY2020 | Dec 31, 2020 | $15.24M | -1.6% |
| Q3 FY2020 | Sep 30, 2020 | $14.42M | -0.6% |
| Q2 FY2020 | Jun 30, 2020 | $39.46M | +150.6% |
| Q1 FY2020 | Mar 31, 2020 | $15.40M | +7.5% |
| Q4 FY2019 | Dec 31, 2019 | $15.50M | – |
| Q3 FY2019 | Sep 30, 2019 | $14.51M | -6.6% |
| Q2 FY2019 | Jun 30, 2019 | $15.75M | +16.4% |
| Q1 FY2019 | Mar 31, 2019 | $14.32M | +12.9% |
| Q4 FY2018 | Dec 31, 2018 | $0 | -100.0% |
| Q3 FY2018 | Sep 30, 2018 | $15.53M | +42.6% |
| Q2 FY2018 | Jun 30, 2018 | $13.52M | +26.2% |
| Q1 FY2018 | Mar 31, 2018 | $12.69M | +19.0% |
| Q4 FY2017 | Dec 31, 2017 | $11.41M | -16.3% |
| Q3 FY2017 | Sep 30, 2017 | $10.89M | +6.1% |
| Q2 FY2017 | Jun 30, 2017 | $10.71M | – |
| Q1 FY2017 | Mar 31, 2017 | $10.67M | – |
| Q4 FY2016 | Dec 31, 2016 | $13.64M | – |
| Q3 FY2016 | Sep 30, 2016 | $10.27M | – |
See a number that looks wrong?